Navigation Links
Aeterna Zentaris Reports Fourth Quarter and Full-Year 2007 Financial and Operating Results
Date:3/5/2008

4,195 5,566 8,964

Impairment of long-lived

asset held for sale 735 - 735 -

-------------------------------------------------------------------------

21,904 18,394 76,822 62,570

-------------------------------------------------------------------------

Loss from operations (11,664) (6,457) (34,754) (23,771)

-------------------------------------------------------------------------

Other revenues (expenses)

Interest income 535 703 1,904 1,441

Interest expense (23) 14 (85) (1,433)

Foreign exchange gain

(loss) (269) 384 (1,035) 319

Loss on disposal of

equipment (28) - (28) -

Gain on disposal of

long-term investment - 409 - 409

Other - (163) - -

-------------------------------------------------------------------------

215 1,347 756 736

-------------------------------------------------------------------------

Share in the results

of an affiliated

company - 1,575 - 1,575

-------------------------------------------------------------------------

Loss before Income taxes (11,449) (3,535) (33,998) (21,460)

Income tax recovery

(expense) (2,405) 26,061 1,961 29,037

-------------------------------------------------------------------------

Net earnings (loss) from

continuing operations (13,854) 22,526 (32,037) 7,577

Net earnings (loss) from

discont
'/>"/>

SOURCE AETERNA ZENTARIS INC.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. AEterna Zentaris and Paladin Labs Announce Sale and Purchase of Miltefosine Rights
2. AEterna Zentaris Announces the Departure of SVP, Administrative and Legal Affairs
3. Aeterna Zentaris to Announce Fourth Quarter and Full-Year 2007 Financial and Operating Results on March 5, 2008
4. AEterna Zentaris to Present at the Upcoming Roth Capital Partners 20th Annual OC Growth Stock Conference in Dana Point, California
5. AEterna Zentaris Reports First Patients Treated with Anti-Cancer Compound AEZS-108 in Phase 2 Trial in Ovarian and Endometrial Cancers
6. AEterna Zentaris to Further Develop Three Follow-up Multi-targeted Cytotoxic Candidates to AEZS-112 as Potential Novel Cancer Treatment
7. AEterna Zentaris Announces Outcome of Managements Strategic Review
8. AEterna Zentaris to Present at Upcoming UBS Global Life Sciences Conference in New York
9. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
10. BioCryst Reports Fourth Quarter and Year End 2007 Financial Results and Corporate Update
11. MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... Cayenne Medical, Inc., a privately ... soft tissue reconstruction segment, announced the worldwide launch ... involving the shoulder and extremities. The SureLock System ... deployment method. The unique delivery eliminates manual tensioning ... or anchor displacement (also commonly know as anchor ...
(Date:7/10/2014)... 2014 Terascala, the industry leader in ... Swahn, a former vice president of product management for ... president of marketing. Terascala’s software when combined with leading ... the highest performance and most reliable solutions for processing ... Terascala’s channel expansion and broaden its product portfolio. His ...
(Date:7/10/2014)... CA (PRWEB) July 10, 2014 Senior ... institutions and professional associations, addressed the challenges of “Reducing ... Medical Device Industries” through strategic sourcing. Describing the partnership ... with the Supply Chain Management Institute ( SCMI) ... event on June 24 at the Kroc Institute of ...
(Date:7/10/2014)... , July 10, 2014 Research and ... of the "International Photonic Integrated Circuit (Monolithic ... to 2019" report to their offering. ... The concept of photonic integration traces its roots ... The promise of photonic integration went unexplored and ...
Breaking Biology Technology:Cayenne Medical Launches SureLock™ All-Suture Anchor System for Shoulder and Extremity Surgery 2Cayenne Medical Launches SureLock™ All-Suture Anchor System for Shoulder and Extremity Surgery 3Terascala Expands Executive Team 2Terascala Expands Executive Team 3Biotech & Biopharm Supply Chain Management Executives Launch BSMA in San Diego 2Biotech & Biopharm Supply Chain Management Executives Launch BSMA in San Diego 3Biotech & Biopharm Supply Chain Management Executives Launch BSMA in San Diego 4International Photonic Integrated Circuit (Monolithic Integration, Hybrid Integration, Module Integration) Market - Forecasts to 2019 2
... Scott Karasinski, PharmD to Run Medical Services Department of ... Expanding Independent Medical Education Agency, ... the appointment of Scott Karasinski, PharmD to the,position of ... as Director in the Medical Affairs and Drug Information,department ...
... Inc., the leading,systems biology tools company, announced today ... and have added additional capability. This,will provide GSK ... access to MetaCore, MapEditor and MetaBase. MetaCore is,GeneGo,s ... data,featuring a comprehensive collection of pathway maps and ...
... at BIO CEO & Investor Conference, LOUISVILLE, Colo., Feb. ... it will host a conference call on,Tuesday, February 26, 2008 ... earnings. Additionally, Replidyne will present at an upcoming,investor conference in ... follows:, Kenneth J. Collins, President and CEO, ...
Cached Biology Technology:L&M Healthcare Communications, LLC, Hires Scott Karasinski, PharmD 2GSK Extends GeneGo License and Adds New Products 2Replidyne to Report 2007 Fourth Quarter and Year-End Earnings 2Replidyne to Report 2007 Fourth Quarter and Year-End Earnings 3
(Date:7/11/2014)... 11, 2014 The increased risk of kidney injury ... resuscitation fluids reflects the mass of HES molecules, according ... official journal of the International Anesthesia Research Society (IARS). ... harmful effect of HES on cultured human renal proximal ... Christian Wunder and colleagues of University Hospital Wrzburg, Austria. ...
(Date:7/11/2014)... exists that cannabinoid receptor type 1 can ... influx, and reduce neurotransmitter release. However, some ... can increase extracellular Ca2+ influx and increase ... team, Tongji Hospital Affiliated to Tongji Medical ... China used whole cell voltage-clamp and calcium ...
(Date:7/10/2014)... Albuquerque, and other major cities in New Mexico, nearly ... municipal wastewater rather than precious potable water supplies. Across ... of all golf courses receive treated effluent. Reusing the ... Additionally, golf courses and homeowners alike fertilize their lawns ... is nitrate. A New Mexico State University turfgrass expert ...
Breaking Biology News(10 mins):In lab studies, hydroxyethyl starch has direct harmful effects on kidney cells 2'Tailored' water -- the latest in lawn care 2
... a person's under stress or injured, the adrenal gland ... normal. But the hormone's effects are many and varied, ... memories with short-term exposure, while impairing learning if there's ... its effects,understanding how cortisol is made is essential to ...
... has emerged as a promising alternative for ... and tissues, circumventing the complications associated with ... or regenerate damaged tissue by using engineered ... regeneration and eventually integrate into the host ...
... and rheumatoid arthritis occur when the immune system fails ... where the molecular breakdowns responsible for such failures occur. ... and the Dana-Farber Cancer Institute have identified a key ... autoimmune disease, findings that may help scientists develop new ...
Cached Biology News:Scientists unravel clue in cortisol production 2Cracking open the black box of autoimmune disease 2
Request Info...
supplied with 10x reaction buffer...
... yeast/leuconostoc overproducer ATP: D-hexose 6- ... One unit of HK will ... in 1 min at 25C ... of G6P-DH will oxidize 1 ...
Request Info...
Biology Products: